Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Non-cash Items (2023 - 2025)

LifeStance Health (LFST) has disclosed Non-cash Items for 3 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-cash Items rose 46.48% to $3.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.4 million, a 46.48% increase, with the full-year FY2025 number at $3.4 million, up 46.48% from a year prior.
  • Non-cash Items was $3.4 million for Q4 2025 at LifeStance Health, up from $2.2 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $23.1 million in Q2 2023 to a low of $1019.0 in Q3 2023.
  • A 3-year average of $4.7 million and a median of $2.3 million in 2024 define the central range for Non-cash Items.
  • Biggest YoY gain for Non-cash Items was 210106.08% in 2024; the steepest drop was 66.32% in 2024.
  • LifeStance Health's Non-cash Items stood at $5.6 million in 2023, then tumbled by 58.67% to $2.3 million in 2024, then soared by 46.48% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Non-cash Items are $3.4 million (Q4 2025), $2.2 million (Q1 2025), and $2.3 million (Q4 2024).